Science Explorer Back to mapMap
Discussion
Topic · Pulmonary and Respiratory Medicine

Aortic Thrombus and Embolism

Aortic Thrombus and Embolism is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 6.7k research works in it since 1950. 10.4% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the association between aortic atherosclerosis and various embolic events, including stroke, renal disease, and peripheral arterial embolism. It explores the diagnosis, treatment, and management of cholesterol embolization syndrome, atheroembolic renal disease, and mobile thrombi in the thoracic aorta. The role of anticoagulation therapy and transesophageal echocardiography in assessing aortic plaque morphology and predicting embolic risk is also discussed.

  • Aortic Atherosclerosis
  • Cholesterol Embolization Syndrome
  • Atheroembolic Renal Disease
  • Thoracic Aorta Plaque
  • Ischemic Stroke
  • Mobile Aortic Thrombus
  • Cerebrovascular Events
  • Atheromatous Plaques
  • Transesophageal Echocardiography
  • Anticoagulation Therapy
Research works
6.7k
fractional, since 1950
In the world top 10%
698
per year above
Top-10% rate
10.4%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+13%
the tick is no change
Largest producer
United States
35% of the 10 largest, 2022-now
Aortic Thrombus and Embolism

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Aortic Thrombus and Embolism research?

By volume, the United States and China publish the most (353 and 174 works in 2022-now).

By volume, 2022-now

  1. 1 United States 353 works
  2. 2 China 174 works
  3. 3 Japan 158 works
  4. 4 Germany 56 works
  5. 5 Italy 54 works
  6. 6 India 49 works
  7. 7 Spain 49 works
  8. 8 France 47 works
  9. 9 United Kingdom 45 works
  10. 10 Australia 26 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 35.0%China: 17.2%Japan: 15.6%Germany: 5.5%6 others listed: 26.6%35%largest
United States353 · 35.0%China174 · 17.2%Japan158 · 15.6%Germany56 · 5.5%6 others listed269 · 26.6%

Shares of the rows listed above, not of the whole node.

Which institutions lead Aortic Thrombus and Embolism research?

By volume in 2022-now, Mayo Clinic publishes the most Aortic Thrombus and Embolism research, followed by Harvard University and Capital Medical University.

By volume, 2022-now

  1. 1 Mayo ClinicUnited States 16 works
  2. 2 Harvard UniversityUnited States 12 works
  3. 3 Capital Medical UniversityChina 11 works
  4. 4 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 7 works
  5. 5 Cleveland ClinicUnited States 7 works
  6. 6 Nihon UniversityJapan 7 works
  7. 7 Ludwig-Maximilians-Universität MünchenGermany 6 works
  8. 8 Yale UniversityUnited States 6 works
  9. 9 University of California, Los AngelesUnited States 5 works
  10. 10 Columbia UniversityUnited States 5 works

Who are the leading researchers in Aortic Thrombus and Embolism?

The most-cited researchers publishing on Aortic Thrombus and Embolism include Emelia J. Benjamin, Stephan Windecker and Graeme J. Hankey.

  1. 1 Emelia J. Benjamin United States 341k citations
  2. 2 Stephan Windecker Switzerland 338k citations
  3. 3 Graeme J. Hankey Australia 316k citations
  4. 4 Gregory Y.H. Lip United Kingdom 311k citations
  5. 5 Salim Yusuf Canada 294k citations
  6. 6 Victoria Delgado Netherlands 269k citations
  7. 7 Valentı́n Fuster United States 257k citations
  8. 8 Ralph B. D’Agostino United States 255k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Aortic Thrombus and Embolism?

The most cited paper in Aortic Thrombus and Embolism is "Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1" (Ahmad Almilaji, Kalina Szteyn, Evelyn Fein et al., 2013), with 8,699 citations. Next come "Embolic strokes of undetermined source: the case for a new clinical construct" (1,689) and "Intraplaque Hemorrhage and Progression of Coronary Atheroma" (1,486).

Most cited papers
#PaperReleasedCitations
1 Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1 Ahmad Almilaji, Kalina Szteyn, Evelyn Fein et al. · Cellular Physiology and Biochemistry Open access 2013 8,699
2 Embolic strokes of undetermined source: the case for a new clinical construct Robert G. Hart, Hans‐Christoph Diener, Shelagh B. Coutts et al. · The Lancet Neurology 20 Mar 2014 1,689
3 Intraplaque Hemorrhage and Progression of Coronary Atheroma Frank D. Kolodgie, Herman K. Gold, ALLEN P. BURKE et al. · New England Journal of Medicine Open access 10 Dec 2003 1,486
4 Coronary Plaque Erosion Without Rupture Into a Lipid Core Andrew A. Farb, ALLEN P. BURKE, Anita L. Tang et al. · Circulation Apr 1996 1,276
5 A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemic Stroke J.P. Mohr, John L.P. Thompson, Ronald M. Lazar et al. · New England Journal of Medicine Open access 15 Nov 2001 1,179
All 100 most cited papers, with filters and sorting

Where is Aortic Thrombus and Embolism research done?

The largest centres of Aortic Thrombus and Embolism research in 2022-now are Tokyo (Japan), Beijing (China), Osaka (Japan) and New York (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Osaka and Tokyo.

Largest cities, 2022-now

  1. 1 TokyoJapan 31 works
  2. 2 BeijingChina 30 works
  3. 3 OsakaJapan 20 works
  4. 4 New YorkUnited States 15 works
  5. 5 GuangzhouChina 12 works
  6. 6 SeoulSouth Korea 12 works
  7. 7 ParisFrance 12 works
  8. 8 PhiladelphiaUnited States 12 works
  9. 9 MadridSpain 12 works
  10. 10 ShanghaiChina 12 works

Where it is the local speciality

  1. OsakaJP · 20.0 works9.3×
  2. TokyoJP · 31.2 works2.9×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Aortic Thrombus and Embolism than the world average.

See Aortic Thrombus and Embolism on the map

Where is the best place to study Aortic Thrombus and Embolism?

Among universities, judged by research, Harvard University and Capital Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 90.010.9%3.2×12 +26.9%
2Capital Medical UniversityChina 20.016.2%8.8×11 +81.0%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Aortic Thrombus and Embolism, country by country

Is Aortic Thrombus and Embolism research growing?

Output in 2022-2025 was 13% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Aortic Thrombus and Embolism.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Aortic Thrombus and Embolism as a percentage of every work published that year, 0.0049% in 2024.

still counting0.0050%0.010%0.015%Aortic Thrombus and Embolism0.0060% in 202519801990200020102020

Fractional works of Aortic Thrombus and Embolism over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Aortic Thrombus and Embolism10.4% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Aortic Thrombus and Embolism. Posts are plain text and can be reported.